Varian Medical Systems

Varian Medical Systems

Radiation oncology technology leader providing TrueBeam linear accelerators, radiosurgery systems, and AI-driven treatment planning software.

Visit Website

Company Overview

Varian Medical Systems is a radiation oncology technology company founded in 1948 as Varian Associates by Russell H. Varian and Sigurd F. Varian, and headquartered in Palo Alto, California. The company designs, manufactures, and sells medical linear accelerators, treatment planning software, and oncology information systems used in cancer radiotherapy centers across more than 100 countries. In April 2021, Siemens Healthineers completed its acquisition of Varian for approximately 16.4 billion US dollars, after which Varian continued operating under its own brand while benefiting from Siemens Healthineers' global sales and service infrastructure.

Varian's flagship product, the TrueBeam radiotherapy system, is an advanced linear accelerator platform engineered to deliver high-dose radiation to tumors in the head and neck, lung, liver, breast, and abdomen with submillimeter precision, expanding treatment options for challenging and motion-affected cases. In February 2024, Varian received FDA 510(k) clearance for the TrueBeam system incorporating the HyperSight imaging solution, which enhances real-time imaging guidance during treatment delivery. The company also manufactures the ProBeam Proton Therapy System, an all-pencil-beam-scanning intensity-modulated proton therapy platform developed in collaboration with the Paul Scherrer Institute in Switzerland, featuring a 360-degree rotating gantry and iterative cone-beam CT imaging.

Varian's RapidArc volumetric arc therapy technology delivers a full three-dimensional dose to a tumor in under two minutes using a rotating gantry in single or multiple arcs, including gated delivery to compensate for respiratory motion in lung and abdominal tumors. At ASTRO 2024, Varian introduced RapidArc Dynamic as an optional feature for the TrueBeam 4.1 delivery platform paired with the Eclipse treatment planning system; early research indicated the technology can reduce organ-at-risk dose by up to 50 percent, accelerate plan optimization and dose calculation by up to 70 percent, and reduce the number of treatment arcs by as much as half. Varian's ARIA oncology information system supports integrated workflow management across radiation therapy, medical oncology, and cancer survivorship programs, and was highlighted alongside imaging innovations at ASTRO 2024 for enabling more personalized patient care pathways.

Capabilities & Activities

Primary type & automation activities this supplier delivers:

Applications & Industries

Product Categories

Products & Solutions

TrueBeam

High-precision radiotherapy linear accelerator for image-guided radiation therapy and radiosurgery.

EDGE Radiosurgery Suite

Dedicated stereotactic radiosurgery system for sub-millimeter precision tumor treatment.

Partnership & Notable clients

Associating Events

Contact Varian Medical Systems

WEBSITE

https://www.varian.com

EMAIL

[email protected]

PHONE

+1 650-493-4000

HEADQUARTERS

3100 Hansen Way
Palo Alto , California  94303

United States

Company Facts

Founded

1948

Primary Role

Manufacturer

Company Size

employees 5000-10000

Primary Region

North America

Annual Sales

-

Funding Stage

-

Funding Total

-

Listed in RobotToday Supplier Discovery. Verified Profile

Related Coverage

Ophthalmic Surgical Robot Achieves Micron-Level Precision in Three Minutes

Ophthalmic Surgical Robot Achieves Micron-Level Precision in Three Minutes

An innovative ophthalmic surgical robot has demonstrated the ability to restore vision in nearly blind patients within just three minutes, achieving precision at the micron level. This advancement in robotic surgery signifies a major leap forward in ophthalmology, potentially transforming treatment options for patients with severe vision impairment. The significance of this technology lies in its ability to perform complex surgical procedures with unprecedented accuracy, which could lead to improved outcomes for patients suffering from various eye conditions. The robot's rapid operation time and high precision could also reduce the overall burden on healthcare systems by streamlining surgical processes. Looking ahead, the continued development and deployment of this ophthalmic surgical robot will be crucial. Stakeholders in the healthcare and robotics sectors should monitor advancements in this technology, as it may pave the way for further innovations in minimally invasive surgical techniques. No further timeline was disclosed at the time of publication.

Robotics Automation AI
IndexBox Forecasts 16.8% Growth in AI Surgical Robot Market by 2035 Amid Surgeon Shortage

IndexBox Forecasts 16.8% Growth in AI Surgical Robot Market by 2035 Amid Surgeon Shortage

According to the latest report by IndexBox, the global AI surgical robot market is entering a structural expansion phase, with demand expected to accelerate before 2035. The market is diversifying into high-end efficiency-driven segments and emerging value-oriented segments, influenced by surgeon shortages and the rising need for minimally invasive surgeries. The significance of this growth lies in the shift from pure institutional procurement to a hybrid model, where preferences of end-surgeons and patient awareness increasingly impact capital equipment purchases. Key demand drivers include advancements in AI and robotics, increased healthcare spending, and the expansion of robotic surgeries into new clinical applications beyond urology and gynecology. Looking ahead, the market is projected to experience a compound annual growth rate of 12.0% from 2026 to 2035, with North America maintaining the largest market share at 40%. No further timeline was disclosed at the time of publication.

AI Surgical Robots Healthcare Technology Robotics Minimally Invasive Surgery Market Trends
CITIC Securities Identifies Turning Point in Medical Device Sector with Focus on Brain-Computer Interfaces and AI Healthcare

CITIC Securities Identifies Turning Point in Medical Device Sector with Focus on Brain-Computer Interfaces and AI Healthcare

CITIC Securities has reported that the medical device sector is reaching a turning point, with opportunities for performance and valuation recovery expected by 2026. The report emphasizes the importance of focusing on companies that are improving their performance and exploring international markets, particularly those listed in Hong Kong. The long-term outlook for the medical device sector is driven by innovation, international expansion, and mergers and acquisitions. The report highlights that the sector's innovative capabilities are gaining recognition, leading to a reconstruction of valuations. Short-term opportunities include capitalizing on performance recovery in high-value consumables and IVD segments, with several leading companies poised for accelerated growth by 2026. Investors are advised to keep an eye on emerging technologies such as surgical robots and brain-computer interfaces, as breakthroughs in these areas are expected to catalyze interest in the sector. The report also notes potential risks, including policy changes, research and development setbacks, and geopolitical uncertainties in the Middle East.

Medical Devices AI Healthcare Brain-Computer Interfaces Surgical Robots Innovation
Newport Hospital Becomes First in Rhode Island to Install Da Vinci Surgical Robot Funded by Donations

Newport Hospital Becomes First in Rhode Island to Install Da Vinci Surgical Robot Funded by Donations

Newport Hospital has become the first facility in Rhode Island to install the Da Vinci Surgical Robot, specifically the Da Vinci 5 model. This advanced robotic-assisted surgical platform, funded entirely by donations after a year of fundraising, will be utilized for minimally invasive surgeries in urology, gynecology, thoracic, and general surgery. The significance of this installation lies in its enhancement of surgical precision and capabilities within a community hospital setting. According to Tenny Thomas, President and Chief Medical Officer of Newport Hospital, this milestone was made possible through the generous support of the donor community. The Da Vinci 5 offers improved force feedback, imaging, and computing power compared to its predecessors, reinforcing the hospital's commitment to providing advanced surgical options. Looking ahead, the integration of the Da Vinci 5 into Newport Hospital's surgical offerings, alongside the Zimmer Biomet ROSA knee system, highlights the ongoing relevance of specialized surgical robots in clinical practice. While humanoid robots like the Yushu G1 are still in early feasibility studies, the successful deployment of the Da Vinci 5 underscores its position as a leading solution in modern surgical procedures.

Surgical Robotics Minimally Invasive Surgery Healthcare Technology Robotic Surgery
Samsung Medical Center Performs First Surgery with Humanoid Robots Assisting Surgeons

Samsung Medical Center Performs First Surgery with Humanoid Robots Assisting Surgeons

On September 16, Samsung Medical Center in Seoul conducted a simulated surgery with two humanoid robots assisting a surgical team. The robots, dressed in surgical attire, successfully collaborated with the lead surgeon, Professor Woo Nam-ki, by retrieving and delivering surgical instruments upon request. This marks a significant advancement in robotic assistance in surgery, showcasing the potential for robots to work alongside human medical professionals. The importance of this development lies in its potential to address staffing challenges in hospitals, particularly in smaller facilities where skilled surgical assistants may be scarce. Professor Jung Yong-ki emphasized that if a robot can effectively replace a human assistant, it could lead to cost-effective solutions for maintaining surgical operations around the clock. The robots demonstrated a 100% success rate in grasping surgical instruments and a 98.7% success rate in instrument delivery, highlighting their reliability in the operating room. Looking ahead, the project is set to progress with plans for commercialization led by Rainbow Robotics and AIDIN ROBOTICS. The first clinical trials are expected to begin in 2029, starting with low-risk endoscopic tasks before expanding to more complex procedures. The ongoing development of AI capabilities, including tactile feedback and predictive analytics, will further enhance the robots' performance in surgical environments.

Humanoid Robots Surgical Robotics AI in Healthcare Medical Technology
Professor Meng Qinghu Recognized as Fellow of the Royal Society of Canada for 2026

Professor Meng Qinghu Recognized as Fellow of the Royal Society of Canada for 2026

Professor Meng Qinghu, head of the Department of Electronic and Electrical Engineering at Southern University of Science and Technology and chief scientist at Yuanhua Intelligent Technology, has been elected as a Fellow of the Royal Society of Canada (RSC) for 2026. He is the only scholar from a mainland Chinese university among the 105 new fellows announced. This recognition highlights Professor Meng's significant contributions to the fields of robotics and intelligent systems, particularly in medical robotics, where he is regarded as a pioneering researcher. His work includes advancements in control algorithms, robotic prosthetics, and orthopedic surgical robots, which have been successfully applied in over 5,000 surgeries, providing substantial clinical value. Looking ahead, Professor Meng's election underscores the growing international recognition of his research and the capabilities of Yuanhua Intelligent Technology in advancing medical robotics technology. No further timeline was disclosed at the time of publication.

Medical Robotics Intelligent Systems Robotics Research AI
Humanoid Robot Successfully Performs Gallbladder Surgery on Live Pigs, According to Nature Study

Humanoid Robot Successfully Performs Gallbladder Surgery on Live Pigs, According to Nature Study

A research team from the University of California, San Diego, utilized the humanoid robot developed by Yushu Technology to perform gallbladder surgeries on live pigs, marking a significant milestone in robotic surgery. This is the first instance of a humanoid robot conducting live surgeries, showcasing its potential in clinical settings. The significance of this research lies in its exploration of humanoid robots in surgical environments, which have traditionally relied on specialized robotic systems like the da Vinci Surgical System. The study highlights the humanoid robot's ability to operate in existing surgical environments without requiring extensive modifications, potentially reducing costs and increasing accessibility. Looking ahead, while the humanoid robot demonstrated notable advancements, it still faces challenges in precision compared to specialized surgical robots. The study indicates that further developments are needed before humanoid robots can be considered for clinical use. No further timeline was disclosed at the time of publication.

Humanoid Robots Surgical Robotics Medical Technology Robotic Surgery
Advancements in Surgical Robots and Real-World Warehouse Automation Explored

Advancements in Surgical Robots and Real-World Warehouse Automation Explored

The September 2026 digital issue of The Robot Report highlights significant advancements in surgical robotics and warehouse automation. It features case studies from El Camino Health, where the da Vinci system from Intuitive Surgical is utilized for coronary artery bypass grafting, emphasizing the need for precise motion control to enhance patient outcomes and reduce complications. This report is crucial for commercial robotics developers and end users as it illustrates the successful integration of robotic systems in healthcare and logistics. El Camino Health's implementation of robotic surgery not only alleviates cognitive burdens on staff but also improves care consistency and accessibility, showcasing the potential of surgical robots in modern medicine. Additionally, the report discusses the integration of autonomous mobile robots (AMRs) in warehouse operations, highlighting their independent capabilities compared to traditional automated guided vehicles. As AMRs become more prevalent in third-party logistics, retailers, and manufacturing, best practices for their deployment and maintenance will be essential for maximizing efficiency and investment returns. No further timeline was disclosed at the time of publication.

Autonomous Mobile Robots (AMRs) Case Study Controllers Digital Issues Healthcare Robotics Logistics
New Insights on Domestic Orthopedic Surgical Robots: Advancements in Complex Joint Replacement

New Insights on Domestic Orthopedic Surgical Robots: Advancements in Complex Joint Replacement

The maturity of surgical robots is evaluated not just by their ability to perform standard joint replacements but also by their effectiveness in complex cases. At the 12th Asian Joint Society Annual Meeting held from September 10 to 12, 2023, in Boao, Hainan, experts discussed the challenges of robotic-assisted surgeries for patients with significant anatomical deviations. The event showcased the Kuntuo® orthopedic surgical robot in various scenarios, including live surgeries and workshops, emphasizing its role in addressing complex cases. A notable case involved a 66-year-old woman with developmental dysplasia of the hip, highlighting the need for personalized planning in joint replacement surgeries. The robot's capabilities extend beyond precision to include individualized preoperative planning based on patient-specific anatomical conditions. Future developments in robotic-assisted surgeries will likely focus on enhancing the robot's ability to adapt to unique anatomical challenges. The Kuntuo robot has previously been utilized in complex cases, indicating its growing relevance in orthopedic surgery. No further timeline was disclosed at the time of publication.

Orthopedic Robotics Surgical Automation Complex Case Management Medical Technology
Impact of Task Complexity on Skill Retention in Surgical Robot Teleoperation Training

Impact of Task Complexity on Skill Retention in Surgical Robot Teleoperation Training

A recent study has revealed the influence of task complexity on skill retention in the teleoperation of surgical robots. This research provides a framework aimed at enhancing training methodologies for surgeons operating robotic systems. Understanding how different levels of task complexity affect surgeons' ability to retain skills is crucial for developing effective training programs. Improved training methods can lead to better surgical outcomes and increased efficiency in robotic surgeries, which is vital in the evolving landscape of medical technology. Looking ahead, the focus will be on implementing the proposed framework in surgical training programs to assess its effectiveness. No further timeline was disclosed at the time of publication.

China’s Dexterous Hand Industry, 2026 Part 3 — The Players

China’s Dexterous Hand Industry, 2026 Part 3 — The Players

Five vendor archetypes, MIR’s composite top ten, eight company profiles and six field deployments — every firm linked to the RobotToday supplier directory.

Inside Saga Robotics: UVC Light vs. Crop Disease

Inside Saga Robotics: UVC Light vs. Crop Disease

Saga Robotics CPO Damian Flynn on the Thorvald platform's UVC treatment system, its jump from UK strawberries to California wine grapes, and why he's “incredibly bullish” on applying automation and robotics into industries “most chaotic environment.”

Introduction to Robotics J. J. Craig — RSF Top 10 Robot Education Textbooks · No. 6

Introduction to Robotics J. J. Craig — RSF Top 10 Robot Education Textbooks · No. 6

Six of ten benchmark universities teach kinematics from Craig. Frames, transforms and D-H parameters: the language vendor manuals already speak.

Faraday Future Completes Six-Series EAI Robot Lineup, Launches Faber Mobile Manipulator

Faraday Future Completes Six-Series EAI Robot Lineup, Launches Faber Mobile Manipulator

Faraday Future unveils its full six-series EAI Robot World portfolio at Automate 2026, featuring the $89,900 All-New Futurist humanoid and the commercial release of the Faber mobile manipulator.

Integrated Joint Actuators 2026: Technology, Global Suppliers & China's Leap Forward

Integrated Joint Actuators 2026: Technology, Global Suppliers & China's Leap Forward

From rotary joints hitting 530 N·m+ to linear joints with planetary roller screws, integrated actuators are replacing the three-part drivetrain. Full supplier map: Tihu, PhyArc, RobStride, Schaeffler, maxon — and China's path from 1,000-RMB modules to global standard-setter.

The Core Components Battle of Indutrial Robot,  Reducers, Servo Systems & Controllers

The Core Components Battle of Indutrial Robot, Reducers, Servo Systems & Controllers

A technology-first analysis of the three pillars driving industrial robot capability: precision reducers, servo systems, and motion controllers. Maps the full global supplier ecosystem — Japan, Europe, and China — from component specs to product generations and integration architectures.

FUTURE WARFARE | Air - Collaborative Combat Aircraft, Drone Motherships & the Autonomy Race Above the Battlefield

FUTURE WARFARE | Air - Collaborative Combat Aircraft, Drone Motherships & the Autonomy Race Above the Battlefield

Anduril’s YFQ-44A Fury flew its first semi-autonomous mission on 31 October 2025 — 556 days from contract to flight. By February 2026 it was carrying live missiles and swapping autonomy software mid-flight. China’s Jiutian drone mothership flew on 11 December 2025, capable of releasing over 100 loitering munitions from its internal bay at 15,000 metres. And the U.S. Air Force is standing up its second experimental one-way attack drone unit for mid-2026. This article maps the most consequential aerial autonomous systems competition in history: the CCA programme that will determine U.S. air dominance in the 2030s, the Valkyrie’s surprising rebirth, the A-GRA open-architecture breakthrough, and the Chinese drone mothership that has no Western equivalent.

Unitree's IPO Review: What It Means for China's Humanoid Robot IPO Landscape

Unitree's IPO Review: What It Means for China's Humanoid Robot IPO Landscape

On 1 April 2026, China's Securities Association (CSAC) randomly selected Unitree Robotics for a mandatory on-site IPO inspection — just 12 days after its STAR Market application was accepted. The event has generated significant market commentary. This analysis examines the regulatory context, what the inspection actually means, the four core controversies in Unitree's prospectus, and the implications for competing humanoid robot companies pursuing public listings.

FUTURE WARFARE | Sea - Autonomous Surface Vessels & Unmanned Underwater Vehicles — The Hybrid Fleet Takes Shape

FUTURE WARFARE | Sea - Autonomous Surface Vessels & Unmanned Underwater Vehicles — The Hybrid Fleet Takes Shape

Ukraine’s ‘Sub Sea Baby’ autonomous torpedo struck a Russian Kilo-class submarine inside Novorossiysk harbour in December 2025 — the first confirmed underwater drone attack on a submarine in history. The U.S. Navy is requesting $5.3 billion for unmanned maritime systems in FY2026, a 70 percent year-on-year increase. Saronic Technologies went from prototype to $392 million production contract in under 12 months. And DARPA’s Manta Ray XL-UUV completed full-scale sea trials. This article maps the maritime autonomous systems revolution — from Ukraine’s improvised Black Sea fleet to the Pentagon’s hybrid manned–unmanned force of the 2030s, and from Saronic’s Franklin, Louisiana shipyard to Boeing’s 85-tonne robot submarine.

Guangdong Huayan Robotics Files for Hong Kong Mainboard IPO

Guangdong Huayan Robotics Files for Hong Kong Mainboard IPO

Guangdong Huayan Robotics (formerly Han’s Robot) files for Hong Kong Mainboard IPO seeking HK$1.37 billion at HK$17.00 per share. China’s leading full-stack cobot manufacturer reported RMB 310.4 million revenue in 2024 (+77% YoY) and carries strong cornerstone backing. Analysis of financial highlights, technology stack, market position, and related-party risk.